{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:56:17Z","timestamp":1767923777663,"version":"3.49.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the cell the second messenger cyclic nucleotides cAMP and cGMP mediate a wide variety of external signals. Both signaling molecules are degraded by the superfamily of phosphodiesterases (PDEs) consisting of more than 50 different isoforms. Several of these PDEs are implicated in disease processes inspiring the quest for and synthesis of selective PDE inhibitors, that unfortunately have led to very mixed successes in clinical trials. This may be partially caused by their pharmacological action. Accumulating data suggests that small differences between different PDE isoforms may already result in specific tissue distributions, cellular localization and different involvement in higher order signal protein complexes. The role of PDEs in these higher order signal protein complexes has only been marginally addressed, as no screening methodology is available to address this in a more comprehensive way. Affinity based chemical proteomics is a relatively new tool to identify specific protein\u2013protein interactions. Here, to study the interactome of PDEs, we synthesized a broad spectrum PDE-capturing resin based on the non-selective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX). Chemical proteomics characterization of this resin in HeLa cell lysates led to the capture of several different PDEs. Combining the IBMX-resin with in-solution competition with the available more selective PDE inhibitors, cilostamide and papaverine, allowed us to selectively probe the interactome of PDE3A in HeLa cells. Besides known interactors such as the family of 14-3-3 proteins, PDE3A was found to associate with a PP2A complex composed of a regulatory, scaffold and catalytic subunit.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1039\/c5mb00142k","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T04:30:39Z","timestamp":1437107439000},"page":"2786-2797","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Charting the interactome of PDE3A in human cells using an IBMX based chemical proteomics approach"],"prefix":"10.1093","volume":"11","author":[{"given":"Eleonora","family":"Corradini","sequence":"first","affiliation":[{"name":"Netherlands Proteomics Centre b , Padualaan 8, 3584 CH Utrecht The Netherlands"},{"name":"Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science Faculty, Utrecht University a , Padualaan 8, 3584 CH Utrecht The Netherlands \u00a0 ascholt1@its.jnj.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gruson","family":"Klaasse","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University c , Universiteitsweg 99, 3584 CG Utrecht The Netherlands \u00a0 N.I.Martin@uu.nl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Leurs","sequence":"additional","affiliation":[{"name":"Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science Faculty, Utrecht University a , Padualaan 8, 3584 CH Utrecht The Netherlands \u00a0 ascholt1@its.jnj.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J R","family":"Heck","sequence":"additional","affiliation":[{"name":"Netherlands Proteomics Centre b , Padualaan 8, 3584 CH Utrecht The Netherlands"},{"name":"Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science Faculty, Utrecht University a , Padualaan 8, 3584 CH Utrecht The Netherlands \u00a0 ascholt1@its.jnj.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel I","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University c , Universiteitsweg 99, 3584 CG Utrecht The Netherlands \u00a0 N.I.Martin@uu.nl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjen","family":"Scholten","sequence":"additional","affiliation":[{"name":"Netherlands Proteomics Centre b , Padualaan 8, 3584 CH Utrecht The Netherlands"},{"name":"Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science Faculty, Utrecht University a , Padualaan 8, 3584 CH Utrecht The Netherlands \u00a0 ascholt1@its.jnj.com"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"key":"2026010815112672700_cit1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0167-4838(86)90174-3","article-title":"Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis","volume":"871","author":"Braumann","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"2026010815112672700_cit2","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1021\/bi00496a018","article-title":"Amino acid sequence of the cyclic GMP stimulated cyclic nucleotide phosphodiesterase from bovine heart","volume":"29","author":"Trong","year":"1990","journal-title":"Biochemistry"},{"key":"2026010815112672700_cit3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"2026010815112672700_cit4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"2026010815112672700_cit5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"key":"2026010815112672700_cit6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BST0340465","article-title":"Compartmentalized cAMP signalling: a personal perspective","volume":"34","author":"Scott","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"2026010815112672700_cit7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1042\/BST0331319","article-title":"Compartmentalization of adenylate cyclase and cAMP signalling","volume":"33","author":"Cooper","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"2026010815112672700_cit8","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1742-4658.2009.06926.x","article-title":"Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases","volume":"276","author":"Baillie","year":"2009","journal-title":"FEBS J."},{"key":"2026010815112672700_cit9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"2026010815112672700_cit10","first-page":"1","article-title":"Phosphodiesterase inhibitors: history of pharmacology","author":"Schudt","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"2026010815112672700_cit11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0021-9258(19)44303-2","article-title":"Separate phosphodiesterases for the hydrolysis of cyclic adenosine 3\u2032,5\u2032-monophosphate and cyclic guanosine 3\u2032,5\u2032-monophosphate in rat liver","volume":"248","author":"Russell","year":"1973","journal-title":"J. Biol. Chem."},{"key":"2026010815112672700_cit12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.coph.2011.09.001","article-title":"PDE3 inhibition in dilated cardiomyopathy","volume":"11","author":"Movsesian","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"2026010815112672700_cit13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-642-17969-3_3","article-title":"Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokinetics","author":"Tenor","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"2026010815112672700_cit14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.111.300003","article-title":"Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart","volume":"112","author":"Beca","year":"2013","journal-title":"Circ. Res."},{"key":"2026010815112672700_cit15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/340245a0","article-title":"A novel genetic system to detect protein\u2013protein interactions","volume":"340","author":"Fields","year":"1989","journal-title":"Nature"},{"key":"2026010815112672700_cit16","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1074\/jbc.274.21.14909","article-title":"The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform","volume":"274","author":"Yarwood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2026010815112672700_cit17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nmeth.2131","article-title":"A high-throughput approach for measuring temporal changes in the interactome","volume":"9","author":"Kristensen","year":"2012","journal-title":"Nat. Methods"},{"key":"2026010815112672700_cit18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-59745-398-1_11","article-title":"Native fractionation: isolation of native membrane-bound protein complexes from porcine rod outer segments using isopycnic density gradient centrifugation","volume":"484","author":"Lange","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"2026010815112672700_cit19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/nmeth.2702","article-title":"Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition","volume":"10","author":"Lambert","year":"2013","journal-title":"Nat. Methods"},{"key":"2026010815112672700_cit20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cbic.200300721","article-title":"Chemical strategies for activity-based proteomics","volume":"5","author":"Speers","year":"2004","journal-title":"ChemBioChem"},{"key":"2026010815112672700_cit21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"2026010815112672700_cit22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1074\/mcp.T600062-MCP200","article-title":"Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry","volume":"6","author":"Wissing","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"2026010815112672700_cit23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cell.2007.08.016","article-title":"Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4","volume":"131","author":"Vermeulen","year":"2007","journal-title":"Cell"},{"key":"2026010815112672700_cit24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/pr0600529","article-title":"Analysis of the cGMP\/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP","volume":"5","author":"Scholten","year":"2006","journal-title":"J. Proteome Res."},{"key":"2026010815112672700_cit25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.yjmcc.2011.06.003","article-title":"Reorganized PKA-AKAP associations in the failing human heart","volume":"52","author":"Aye","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2026010815112672700_cit26","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/bi049868i","article-title":"Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity","volume":"43","author":"Scapin","year":"2004","journal-title":"Biochemistry"},{"key":"2026010815112672700_cit27","doi-asserted-by":"crossref","first-page":"30949","DOI":"10.1074\/jbc.M504398200","article-title":"Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7","volume":"280","author":"Wang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2026010815112672700_cit28","doi-asserted-by":"crossref","first-page":"21469","DOI":"10.1074\/jbc.M512527200","article-title":"Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2026010815112672700_cit29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.107.040212","article-title":"Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil","volume":"73","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"2026010815112672700_cit30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/156802607779941242","article-title":"Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity","volume":"7","author":"Ke","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"2026010815112672700_cit31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0223-5234(90)90130-U","article-title":"Structure\u2013activity relationships in a series of xanthine derivatives with antibronchoconstrictory and bronchodilatory activities","volume":"25","author":"Merlos","year":"1990","journal-title":"Eur. J. Med. Chem."},{"key":"2026010815112672700_cit32","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1021\/jm049787k","article-title":"Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists","volume":"47","author":"Hartz","year":"2004","journal-title":"J. Med. Chem."},{"key":"2026010815112672700_cit33","first-page":"pp. 41\u201364","volume-title":"Phosphodiesterase Inhibitors","author":"Rabe","year":"1996"},{"key":"2026010815112672700_cit34","doi-asserted-by":"crossref","first-page":"M111 014050","DOI":"10.1074\/mcp.M111.014050","article-title":"Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins","volume":"11","author":"Geiger","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"2026010815112672700_cit35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)31785-4","article-title":"Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation","volume":"211","author":"Hidaka","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026010815112672700_cit36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"2026010815112672700_cit37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nprot.2009.21","article-title":"Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics","volume":"4","author":"Boersema","year":"2009","journal-title":"Nat. Protoc."},{"key":"2026010815112672700_cit38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00216-012-6070-z","article-title":"Applications of stable isotope dimethyl labeling in quantitative proteomics","volume":"404","author":"Kovanich","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"2026010815112672700_cit39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20051103","article-title":"Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428","volume":"392","author":"Pozuelo Rubio","year":"2005","journal-title":"Biochem. J."},{"key":"2026010815112672700_cit40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj20031797","article-title":"14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking","volume":"379","author":"Rubio","year":"2004","journal-title":"Biochem. J."},{"key":"2026010815112672700_cit41","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M403044200","article-title":"Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins","volume":"279","author":"Meek","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026010815112672700_cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2005.09.019","article-title":"NRH:quinone reductase 2: an enzyme of surprises and mysteries","volume":"71","author":"Vella","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"2026010815112672700_cit43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1073\/pnas.0608659104","article-title":"Activity-based probes for proteomic profiling of histone deacetylase complexes","volume":"104","author":"Salisbury","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026010815112672700_cit44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1039\/b815709j","article-title":"A chemical proteomics based enrichment technique targeting the interactome of the PDE5 inhibitor PF-4540124","volume":"5","author":"Dadvar","year":"2009","journal-title":"Mol. BioSyst."},{"key":"2026010815112672700_cit45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1146\/annurev.pharmtox.41.1.751","article-title":"Compartmentation of G protein-coupled signaling pathways in cardiac myocytes","volume":"41","author":"Steinberg","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2026010815112672700_cit46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"issue":"pt 3","key":"2026010815112672700_cit47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/bj3410839","article-title":"Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine\/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A","volume":"341","author":"Resj\u00f6","year":"1999","journal-title":"Biochem. J."},{"key":"2026010815112672700_cit48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(99)00074-5","article-title":"Protein phosphatase 2A: a panoply of enzymes","volume":"12","author":"Virshup","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"2026010815112672700_cit49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.18388\/abp.2001_3858","article-title":"Protein phosphatase 2A: variety of forms and diversity of functions","volume":"48","author":"Lechward","year":"2001","journal-title":"Acta Biochim. Pol."},{"key":"2026010815112672700_cit50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gde.2004.12.004","article-title":"PP2A: the expected tumor suppressor","volume":"15","author":"Janssens","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2026010815112672700_cit51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/msb.2008.75","article-title":"An integrated workflow for charting the human interaction proteome: insights into the PP2A system","volume":"5","author":"Glatter","year":"2009","journal-title":"Mol. Syst. Biol."},{"key":"2026010815112672700_cit52","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.93.25.14440","article-title":"Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels","volume":"93","author":"Shevchenko","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026010815112672700_cit53","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/pr1011729","article-title":"Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos","volume":"10","author":"Frese","year":"2011","journal-title":"J. Proteome Res."},{"key":"2026010815112672700_cit54","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1074\/mcp.M113.035154","article-title":"Alterations in the cerebellar (Phospho)proteome of a cyclic guanosine monophosphate (cGMP)-dependent protein kinase knockout mouse","volume":"13","author":"Corradini","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"2026010815112672700_cit55","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Vizcaino","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular BioSystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/11\/10\/2786\/65458496\/c5mb00142k.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/11\/10\/2786\/65458496\/c5mb00142k.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:18:37Z","timestamp":1767903517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/11\/10\/2786\/8324039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,7,17]]}},"URL":"https:\/\/doi.org\/10.1039\/c5mb00142k","relation":{},"ISSN":["1742-2051","1742-206X"],"issn-type":[{"value":"1742-2051","type":"electronic"},{"value":"1742-206X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,10,1]]},"published":{"date-parts":[[2015,7,17]]},"assertion":[{"value":"This document is Similarity Check deposited","name":"similarity_check","explanation":{"URL":"https:\/\/www.crossref.org\/services\/similarity-check\/"},"group":{"name":"similarity_check","label":"SIMILARITY CHECK"}},{"value":"Supplementary Information","URL":"https:\/\/doi.org\/10.1039\/C5MB00142K","name":"related_data","group":{"name":"related_data","label":"RELATED DATA"}},{"value":"The Royal Society of Chemistry has an exclusive publication licence for this journal","name":"copyright_licence","group":{"name":"copyright_licensing","label":"COPYRIGHT AND LICENSING"}},{"value":"Single-blind","order":2,"name":"peer_review_method","group":{"name":"peer_review_method","label":"PEER REVIEW METHOD"}},{"value":"Received 19 February 2015; Accepted 16 July 2015; Accepted Manuscript published 17 July 2015; Advance Article published 24 July 2015; Version of Record published 15 September 2015","order":1,"name":"history","group":{"name":"publication_history","label":"PUBLICATION HISTORY"}}]}}